Global /United States /Healthcare /Medical Devices /NDRA

ENDRA Life Sciences Inc.

NDRA

• NASDAQ: NDRA • Delayed

4.85USD 5.8%

As of 15 June 2026, ENDRA Life Sciences Inc. has a market cap of $6.02M USD, ranking #43698 globally and #5583 in the United States. It ranks #3875 in the Healthcare sector, and #817 in the Medical Devices industry.

Global Rank

43698

Country Rank

5583

Sector Rank

3875

Industry Rank

817

Key Stats

Market Cap

$6.02MUSD

Enterprise Value

$5.74MUSD

EBITDA (TTM)

-$5.72MUSD

Net Income (TTM)

-$7.03MUSD

PB Ratio

2.4

Company Profile

Country (HQ)

United States

Sector

Healthcare

Industry

Medical Devices

CEO

Alexander Tokman open_in_new

Employees

Founded

2007

IPO

09 May 2017

Website

endrainc.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
5.8%	-7.2%	10%	5.3%	-9%	6%	12%	-100%	-100%

News

NDRA Analyst Forecasts

Markets

Exchange	Ticker	Price	Quotes
NASDAQ MIC: XNAS PRIMARY	NDRA ENDRA Life Sciences Inc Registered Shs ISIN: US29273B5003 Shares Out.: Shares Outstanding: 1.27M¹ Shares Float: 674.533K² TV: TradingView: NASDAQ: NDRA SA: Stock Analysis: NASDAQ: NDRA YF: Yahoo Finance: NDRA GF: Google Finance: NASDAQ: NDRA NQ: NASDAQ: NDRA BA: Barron's: NDRA MS: Morningstar: XNAS: NDRA	4.85 USD	TV: TradingView: NASDAQ: NDRA SA: Stock Analysis: NASDAQ: NDRA YF: Yahoo Finance: NDRA GF: Google Finance: NASDAQ: NDRA NQ: NASDAQ: NDRA BA: Barron's: NDRA MS: Morningstar: XNAS: NDRA

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About ENDRA Life Sciences Inc.

ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is involved in the development of thermo-acoustic enhanced ultrasound technology that uses pulsed energy source comprising radio frequency to transmit energy deep into tissue and generate ultrasonic waves to create high-contrast images for use in the treatment of non-alcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.

Similar Companies

Industry: Medical Devices (United States)

Name	Market Cap (USD) diff.	PE	Country
Thermo Fisher Scientific Inc. NYSE: TMO	$173.27B 3M%	25.8	United States
Intuitive Surgical, Inc. NASDAQ: ISRG	$160.73B 3M%	56.7	United States
Abbott Laboratories NYSE: ABT	$159.07B 3M%	25.6	United States
Danaher Corp. NYSE: DHR	$126.55B 2M%	34.7	United States
Stryker Corp. NYSE: SYK	$120.69B 2M%	38.3	United States
Boston Scientific Corp. NYSE: BSX	$84.93B 1M%	24.5	United States

Industry: Medical Devices (Global)

Name	Market Cap (USD) diff.	PE	Country
Medtronic plc NYSE: MDT	$101.9B 2M%	22.2	Ireland
EssilorLuxottica Société anonyme EPA: EL	$97.46B 84.32B EUR 2M%	36.7	France
HOYA Corp. TSE: 7741	$61.41B 9.83T JPY 1M%	40.0	Japan
Siemens Healthineers AG XETRA: SHL	$45.47B 39.34B EUR 756K%	18.7	Germany
Alcon Inc. SIX: ALC	$36.38B 28.99B CHF 604K%	37.9	Switzerland
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. SHE: 300760	$30.06B 203.66B CNY 499K%	26.0	China

chevron_leftBack